Nasdaq Listing Rule 5635(c)(4) is the regulatory basis for a restricted stock unit grant the Compensation Committee of QuidelOrtho Corporation's (Nasdaq: QDEL) Board of Directors approved on July 15, 2026. QuidelOrtho, based in San Diego and listed on Nasdaq under the ticker QDEL, describes itself as a leading global provider of diagnostic solutions. The announcement, distributed through PRNewswire, classified the equity award as an inducement grant.
Approving body
The Compensation Committee of the Board of Directors is the named authority that cleared the RSU award. The committee's scope covers equity compensation decisions at the company, and its clearance on July 15 formally established the grant under the cited Nasdaq rule.
Disclosure scope
The July 15 announcement confirms the grant vehicle (RSUs), the approving committee, and the applicable Nasdaq rule. Grant size in units, recipient identities, vesting schedules, and implied dilution figures were not included in the materials distributed through PRNewswire. The disclosure available as of that date does not extend beyond the grant classification and the rule invoked.
Source: QuidelOrtho Corporation press release via PRNewswire, July 15, 2026. The summary was partially truncated; this article reflects only the facts available in the disclosed text.